Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Johnsen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 7, 2003
Stromal cell involvement in cancerKasper Almholt, Morten Johnsen
Oncogene|July 11, 2003
Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient miceKasper Almholt, Boye S Nielsen, Thomas L Frandsen, et al.
Neuro-Oncology Practice|May 11, 2026
Evaluating work activity and societal burden in patients with grade 2 IDH-mutant gliomaSlávka Lukacova, Aida Muhic, Oskar Ström, et al.
Clinical & Experimental Metastasis|September 22, 2012
Spontaneous metastasis in congenic mice with transgenic breast cancer is unaffected by plasminogen gene ablationKasper Almholt, Anna Juncker-Jensen, Ole Didrik Lærum, et al.
Thrombosis and Haemostasis|April 21, 2005
Plasminogen activation and cancerKeld Danø, Niels Behrendt, Gunilla Høyer-Hansen, et al.
International Journal of Cancer|October 9, 2004
Reduced metastasis of transgenic mammary cancer in urokinase-deficient miceKasper Almholt, Leif R Lund, Jørgen Rygaard, et al.
Molecular Cancer Therapeutics|September 16, 2008
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer modelKasper Almholt, Anna Juncker-Jensen, Ole Didrik Laerum, et al.
The Journal of Investigative Dermatology|March 14, 2008
Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogenKirsty A Green, Kasper Almholt, Michael Ploug, et al.
International Journal of Cancer|October 30, 2004
Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissuePernille Autzen Usher, Ole Frøkjaer Thomsen, Peter Iversen, et al.
Oncogene|June 19, 2003
Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinomaTanja Xenia Pedersen, Chidchanop Leethanakul, Vyomesh Patel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 7, 2003
Stromal cell involvement in cancerKasper Almholt, Morten Johnsen
Oncogene|July 11, 2003
Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient miceKasper Almholt, Boye S Nielsen, Thomas L Frandsen, et al.
Neuro-Oncology Practice|May 11, 2026
Evaluating work activity and societal burden in patients with grade 2 IDH-mutant gliomaSlávka Lukacova, Aida Muhic, Oskar Ström, et al.
Clinical & Experimental Metastasis|September 22, 2012
Spontaneous metastasis in congenic mice with transgenic breast cancer is unaffected by plasminogen gene ablationKasper Almholt, Anna Juncker-Jensen, Ole Didrik Lærum, et al.
Thrombosis and Haemostasis|April 21, 2005
Plasminogen activation and cancerKeld Danø, Niels Behrendt, Gunilla Høyer-Hansen, et al.
International Journal of Cancer|October 9, 2004
Reduced metastasis of transgenic mammary cancer in urokinase-deficient miceKasper Almholt, Leif R Lund, Jørgen Rygaard, et al.
Molecular Cancer Therapeutics|September 16, 2008
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer modelKasper Almholt, Anna Juncker-Jensen, Ole Didrik Laerum, et al.
The Journal of Investigative Dermatology|March 14, 2008
Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogenKirsty A Green, Kasper Almholt, Michael Ploug, et al.
International Journal of Cancer|October 30, 2004
Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissuePernille Autzen Usher, Ole Frøkjaer Thomsen, Peter Iversen, et al.
Oncogene|June 19, 2003
Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinomaTanja Xenia Pedersen, Chidchanop Leethanakul, Vyomesh Patel, et al.
Pageof 2